Man Group’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-252,676
| Closed | -$945K | – | 2021 |
|
|
2023
Q4 | $945K | Buy |
+252,676
| New | +$945K | ﹤0.01% | 1359 |
|
|
2023
Q3 | – | Sell |
-173,940
| Closed | -$828K | – | 1509 |
|
|
2023
Q2 | $828K | Buy |
+173,940
| New | +$828K | ﹤0.01% | 1419 |
|
|
2023
Q1 | – | Sell |
-93,837
| Closed | -$947K | – | 1568 |
|
|
2022
Q4 | $947K | Buy |
93,837
+76,537
| +442% | +$772K | ﹤0.01% | 1330 |
|
|
2022
Q3 | $388K | Buy |
+17,300
| New | +$388K | ﹤0.01% | 1563 |
|
|
2022
Q1 | – | Sell |
-12,430
| Closed | -$727K | – | 2062 |
|
|
2021
Q4 | $727K | Buy |
+12,430
| New | +$727K | ﹤0.01% | 1411 |
|
|
2021
Q2 | – | Sell |
-6,212
| Closed | -$512K | – | 1917 |
|
|
2021
Q1 | $512K | Sell |
6,212
-73,111
| -92% | -$6.03M | ﹤0.01% | 1470 |
|
|
2020
Q4 | $7.21M | Sell |
79,323
-25,977
| -25% | -$2.36M | 0.03% | 593 |
|
|
2020
Q3 | $4.21M | Buy |
105,300
+78,133
| +288% | +$3.12M | 0.02% | 897 |
|
|
2020
Q2 | $932K | Buy |
+27,167
| New | +$932K | ﹤0.01% | 1292 |
|